Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma

Shibata,Takahiro; Matsuo,Yoichi; Shamoto,Tomoya; Hirokawa,Takahisa; Tsuboi,Ken; Takahashi,Hiroki; Ishiguro,Hideyuki; Kimura,Masahiro; Takeyama,Hiromitsu; Inagaki,Hiroshi

doi:10.3892/or.2013.2406

Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma

Authors:
- Takahiro Shibata
- Yoichi Matsuo
- Tomoya Shamoto
- Takahisa Hirokawa
- Ken Tsuboi
- Hiroki Takahashi
- Hideyuki Ishiguro
- Masahiro Kimura
- Hiromitsu Takeyama
- Hiroshi Inagaki
View Affiliations

Affiliations: Department of Gastroenterological Surgery, Nagoya City University, Nagoya, Aichi 4678601, Japan, Department of Anatomic Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Aichi 4678601, Japan
Published online on: April 12, 2013 https://doi.org/10.3892/or.2013.2406
Pages: 2127-2132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Girdin, an actin-binding Akt substrate, regulates actin reconstruction and Akt-dependent cell motility in fibroblasts and in a human breast cancer cell line. We examined whether Girdin is also involved in the motility of esophageal squamous cell carcinoma (ESCC) cells. Immunofluorescent staining and migration assays were performed, using KYSE cell lines, to examine whether Girdin is involved in the motility of ESCC cells. Upon EGF stimulation, Girdin colocalized with filamentous actin (F-actin) in the lamellipodia as determined by immunofluorescent staining. In migration assays, cell motility was significantly reduced in KYSE cell lines transfected with Girdin siRNA compared with the negative control. In addition, we examined the relationship between Girdin expression and clinical data, using specimens resected from ESCC patients. In immunohistochemical (IHC) analyses using specimens resected from ESCC patients, overall survival was significantly longer in cases showing lower Girdin expression compared to cases with higher Girdin expression. Collectively, Girdin appears to be involved in the motility of ESCC cells. The levels of Girdin expression correlated inversely with the survival of ESCC patients. Therefore, in ESCC, Girdin may be a prognostic marker and may serve as a therapeutic target as well.

View Figures

View References

1	Kuwano H, Nakajima M, Miyazaki T and Kato H: Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg. 9:6–13. 2003.PubMed/NCBI
2	Ando N, Ozawa S, Kitagawa Y, Shinozawa Y and Kitajima M: Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 232:225–232. 2000.PubMed/NCBI
3	Hofstetter W, Swisher SG, Correa AM, et al: Treatment outcomes of resected esophageal cancer. Ann Surg. 236:376–384. 2002. View Article : Google Scholar : PubMed/NCBI
4	Boyce GA and Boyce BH: Esophagus. Text of Gastro-enterology. Yamada TY, Alpers DH and Laine L: Lippincott Williams and Wilkins; Philadelphia, PA: pp. 1180–1195. 2003
5	Yamazaki D, Kurisu S and Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96:379–386. 2005. View Article : Google Scholar : PubMed/NCBI
6	Enomoto A, Murakami H, Asai N, et al: Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell. 9:389–402. 2005. View Article : Google Scholar : PubMed/NCBI
7	Jiang P, Enomoto A, Jijiwa M, et al: An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res. 68:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
8	Rivas RJ and Hatten ME: Motility and cytoskeletal organization of migrating cerebellar granule neurons. J Neurosci. 15:981–989. 1995.PubMed/NCBI
9	Trivers KF, Sabatino SA and Stewart SL: Trends in esophageal cancer incidence by histology, United States, 1998–2003. Int J Cancer. 123:1422–1428. 2008.
10	Ide H, Udagawa H, Ozawa S, et al: The Japanese Society for Esophageal Diseases: Comprehensive registry of esophageal cancer in Japan (1998,1999). The Japanese Society for Esophageal Diseases; Tokyo: 2002
11	Ozawa S, Tachimori Y, Baba H, et al: Comprehensive registry of esophageal cancer in Japan, 2002. Esophagus. 7:7–22. 2010. View Article : Google Scholar
12	Harris AK: A dozen questions about how tissue cells crawl. Biochem Soc Symp. 65:315–341. 1999.PubMed/NCBI
13	Roy S, Miao F and Qi HJ: Cell crawling assisted by contractile stress induced retraction. J Biomech Eng. 132:0610052010. View Article : Google Scholar : PubMed/NCBI
14	Olson MF and Sahai E: The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis. 26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
15	Machesky LM and Hall A: Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J Cell Biol. 138:913–926. 1997. View Article : Google Scholar : PubMed/NCBI
16	Welch MD: The world according to Arp: regulation of actin nucleation by the Arp2/3 complex. Trends Cell Biol. 9:423–427. 1999. View Article : Google Scholar : PubMed/NCBI
17	Ohta Y, Suzuki N, Nakamura S, Hartwig JH and Stossel TP: The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA. 96:2122–2128. 1999. View Article : Google Scholar : PubMed/NCBI
18	Altomare DA and Khaled AR: Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling. Curr Med Chem. 19:3748–3762. 2012. View Article : Google Scholar : PubMed/NCBI
19	Qian Y, Corum L, Meng Q, et al: PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am J Physiol Cell Physiol. 286:C153–C163. 2004. View Article : Google Scholar : PubMed/NCBI
20	Garcia-Marcos M, Jung BH, Ear J, Cabrera B, Carethers JM and Ghosh P: Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer. FASEB J. 25:590–599. 2011. View Article : Google Scholar : PubMed/NCBI
21	Lin YC, Wu MY, Li DR, Wu XY and Zheng RM: Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol. 10:3235–3239. 2004.PubMed/NCBI
22	Shimada Y, Imamura M, Shibagaki I, et al: Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Ann Surg. 226:162–168. 1997. View Article : Google Scholar : PubMed/NCBI
23	Ren Y, Cao B, Law S, et al: Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res. 11:6190–6197. 2005. View Article : Google Scholar : PubMed/NCBI
24	Konishi S, Ishiguro H, Shibata Y, et al: Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer. 95:2473–2478. 2002. View Article : Google Scholar : PubMed/NCBI
25	Terashita Y, Ishiguro H, Haruki N, et al: Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer. Oncol Rep. 12:827–831. 2004.PubMed/NCBI
26	Takashima N, Ishiguro H, Kuwabara Y, et al: Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. Oncol Rep. 15:667–671. 2006.PubMed/NCBI